StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BioMarin Pharma (BMRN) Climbs Following Hemophilia A Gene Therapy Data from Rival Spark Therapeutics (ONCE)
August 7, 2018 8:20 AM
BioMarin Pharma (NASDAQ: BMRN) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Trader Talk
Next Articles
Spark Therapeutics (ONCE) PT Lowered to $61 at SunTrust Robinson Humphrey
August 7, 2018 3:32 PM
Spark Therapeutics (ONCE) PT Lowered to $80 at Cowen
August 7, 2018 3:31 PM
Spark Therapeutics (ONCE) PT Lowered to $64 at RBC Capital
August 7, 2018 2:31 PM
Cantor Fitzgerald Defends Spark Therapeutics (ONCE), Saying They Didn't Expect Perfection
August 7, 2018 9:34 AM
Spark Therapeutics (ONCE) Reports Q2 Loss Per Share of $2.07
August 7, 2018 7:35 AM
Spark Therapeutics Reports Second Quarter 2018 Financial Results and Recent Business Progress
August 7, 2018 7:30 AM
